2015-08-18 17:35:00 |
ASX Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d509334ad2c9ab0f89383b40474a080a |
Admission to Official List
|
2015-08-18 17:42:00 |
ASX Admission Market Release |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4602c14e1a15809a84bf91fa92642244 |
Admission to Official List
Commencement of Official Quotation
|
2015-08-18 17:49:00 |
Prospectus |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0cefe2dcb422cec1ce76e270904a9daa |
|
2015-08-18 17:50:00 |
Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/be3b0febcdb7db19ec79c98ed2ceb8b1 |
|
2015-08-18 17:52:00 |
Appendix 1A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cc846208b3ab806e56baa80ada43e69 |
Admission to Official List
Stock Exchange Announcement - Other
|
2015-08-18 17:54:00 |
Information Form and Checklist |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4aa467e340aa66f7b22eee53cb86b75 |
Admission to Official List
Company Administration - Other
|
2015-08-18 17:55:00 |
Financial statements for period from 2 May to 30 June 2014 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad6ed594184cc116e99c311195d8e591 |
Admission to Official List
|
2015-08-18 17:57:00 |
Financial statements from 1 July 2014 to 31 March 2015 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/67e437ebff23567eb3d23211e8de87c2 |
Admission to Official List
|
2015-08-18 17:57:00 |
Distribution Schedule |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92a0315c2e88e254cc49088994ef4c33 |
Admission to Official List
|
2015-08-18 17:57:00 |
Top 20 Holders List |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d4ba1b8720887ccceddbbfa8395918a |
Admission to Official List
|
2015-08-18 18:00:00 |
Corporate Governance Policies |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b967fa337b5baf6ddbe8e5f295423ab3 |
Admission to Official List
|
2015-08-18 18:01:00 |
Pre-quotation disclosure |
0 |
https://app.sharelinktechnologies.com/announcement/asx/40e4936dbc8dbf4d0a4d80ddd13bf30b |
Admission to Official List
Company Administration - Other
|
2015-08-21 16:08:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/41791fcfe4260e7914b2e1ad1037f109 |
Becoming a substantial holder
|
2015-08-21 17:18:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/722abcd1c60efa462ed030927d549f64 |
Initial Director's Interest Notice
|
2015-08-21 17:18:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b76f1bbe8cbd671c8c58701cb572b5c2 |
Initial Director's Interest Notice
|
2015-08-21 17:20:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4ce4c3ab2fade3850d4e08b720f5ea13 |
Initial Director's Interest Notice
|
2015-08-21 17:27:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/14bfd03b482e0775bb7cc8dcdb0e7dc3 |
Initial Director's Interest Notice
|
2015-08-24 09:31:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17539068c8f03a8acffe6837727f09bb |
Becoming a substantial holder
|
2015-08-24 09:31:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6ad976422c1431ad80d487be6a74c2e |
Becoming a substantial holder
|
2015-08-24 09:46:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb3f4dfec600cdcbf432f719c10911d9 |
Becoming a substantial holder
|
2015-08-24 11:31:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64d7f18fdf9fc143184d4109bf850937 |
Becoming a substantial holder
|
2015-08-26 09:59:00 |
Paradigm Secures Key US Patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/31c7f01f60ced7bce01c665eb76f08a1 |
|
2015-08-31 15:39:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/97a60f32b759c14f1a7d44a40e0fa1fe |
|
2015-09-28 11:13:00 |
2015 Annual Report |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c9f24babb45a3e6680e017b14ab891e |
Full Year Directors' Statement
Full Year Directors' Report
|
2015-09-28 11:19:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af15939fef021bd595367f2fc1f90502 |
|
2015-09-28 11:29:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e4ad10180f284d8bd6251775c34943f3 |
Notice of Annual General Meeting
|
2015-10-22 14:02:00 |
Shares released from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17931d717bfbfba7af16b701b776ccf8 |
|
2015-10-28 11:48:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/09ca965a79ebd052f380b2d532ff7827 |
Commitments Test Entity - First Quarter Report
|
2015-10-30 11:03:00 |
CEO AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abd30b09f8fa42d696211b78afd9c108 |
Chairman's Address to Shareholders
|
2015-10-30 15:38:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f89257b932d38a2bd3d799530a4cb693 |
|
2015-11-10 13:41:00 |
Appendix 3B - Release from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2b3f841c17c5be0f7bb3ea7b8a5df84f |
|
2015-11-23 10:45:00 |
Paradigm Biopharmaceuticals Receives Ethics Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b8081990079309085f8d5d7adf9f2b86 |
|
2015-12-03 09:52:00 |
Elite Athlete successfully treated with Paradigm's Zilosul |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3d91d0e5d607e506e398ad7c443299c5 |
|
2015-12-14 17:16:00 |
Appendix 3Y |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a8fa1f0fc647bc65b68ce864ba6684af |
Change of Director's Interest Notice
|
2015-12-15 09:19:00 |
European Patent Office Grants PAR Key Respiratory Patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dc7cca48d4ad8c49a875fe8caa18ae03 |
|
2016-01-27 11:42:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cbef3b57e5cd145e20d152061ec10843 |
Commitments Test Entity - Second Quarter Report
|
2016-02-23 09:08:00 |
Paradigm starts Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dcaad8366234169a0aa675d1bd84ce88 |
|
2016-02-25 08:41:00 |
First Participant treated in Paradigms Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/292d965084dc858b62a64d31dad91920 |
|
2016-02-25 14:15:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0b10124b82daa60623740a19932f1ff8 |
Half Year Directors' Statement
Half Year Directors' Report
|
2016-03-02 08:36:00 |
Paradigm initiates second clinical trial site |
1 |
https://app.sharelinktechnologies.com/announcement/asx/90a1952c6c98a3a629443c962c97781c |
|
2016-03-15 19:21:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d30c74693b963703eecec9a4e2ff4b91 |
Change in substantial holding
|
2016-03-15 19:25:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/30cbafdb06c6075b1fb82a3f71f60401 |
Change of Director's Interest Notice
|
2016-03-16 09:10:00 |
Paradigms Updated Investor Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/77cc113adafe9bf9d4144cb2f910e203 |
|
2016-04-14 14:54:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/07ae1a7869566c81d3f29703ee9deabf |
Commitments Test Entity - Third Quarter Report
|
2016-04-21 10:33:00 |
Shares released from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e388a849eab322df9c6ced8d5978b9b0 |
Alteration to issued capital
|
2016-05-09 14:17:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/75a3c0757340b3b0c675d3be3f385cde |
|
2016-05-25 10:21:00 |
Investor Update Hayfever Allergic Rhinitis |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2310aaa94c95f2b2feb978830e1202e3 |
|
2016-06-09 09:55:00 |
Shareholders Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ae643fd5da9d2b1908e8080ca1938c8f |
|
2016-06-09 09:57:00 |
Baker Young Stockbrokers Initiates Coverage on Paradigm |
0 |
https://app.sharelinktechnologies.com/announcement/asx/37d5da9ea01aa318f2ff13898f895e39 |
|
2016-06-20 09:26:00 |
Investor Roadshow Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b4dd3beb8f21f2c4bffa59f205d5732 |
|
2016-07-21 16:24:00 |
Shares released from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/205c08484b1dd88969ba58586f152664 |
|
2016-07-28 17:37:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/57cc058b834821f99f0304bcdb29009d |
Commitments Test Entity - Fourth Quarter Report
|
2016-08-12 14:29:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f215eb0fab3f50cdc3e9f3f39f73e02b |
|
2016-08-19 09:42:00 |
Paradigm PPS nasal spray to treat Allergic Rhinitis |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2e142b42829d4df3f72cf712ece1820c |
|
2016-08-31 16:57:00 |
Preliminary Final Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/02f72734688606e71f1079df96fb0133 |
|
2016-08-31 17:02:00 |
Full Year Statutory Accounts |
0 |
https://app.sharelinktechnologies.com/announcement/asx/745a3db65a82f3e3ed9f6e4e6818aae7 |
Full Year Directors' Statement
Full Year Directors' Report
|
2016-08-31 17:05:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6628a6c8349a6a1855f14ba2a27a53c3 |
|
2016-09-07 08:51:00 |
Paradigm PPS a potential in the treatment of viral arthritis |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3888777af160f3262e1e6a88ba4d6f93 |
|
2016-09-13 11:37:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b482f02a6148beb2dabd6e025c41cb8 |
Change of Director's Interest Notice
|
2016-09-16 09:07:00 |
Preclinical study underpins efficacy of Paradigm's RhinosulR |
1 |
https://app.sharelinktechnologies.com/announcement/asx/549d787cb32a5daea7f540f013c487ee |
|
2016-10-12 12:45:00 |
Paradigm Biopharmaceuticals updated corporate presentati |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3fe9229608cc0045fb6217ed47434f8f |
|
2016-10-14 09:34:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ab7cdb9ff1dc4a5b5643318fdde02a93 |
|
2016-10-18 09:14:00 |
Paradigms Placement heavily oversubscribed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e736bd357081d8f0f43c22523ef14003 |
|
2016-10-21 09:18:00 |
PAR Share Purchase Plan 2016 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cee50884443273e9caaa1c746e0d0506 |
|
2016-10-28 09:59:00 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/66a8a33d21b4c396c81ff8353e2accee |
Notice of Annual General Meeting
|
2016-10-28 11:50:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fbddc191470f10a78135db6e0e659792 |
|
2016-10-28 12:15:00 |
Appendix 4C - September 2016 quarter |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3932659982c23d10180be9800ffe4131 |
Commitments Test Entity - First Quarter Report
|
2016-10-28 16:37:00 |
Cleansing Notice - Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0470aa3c572a536cf1222da044d62225 |
|
2016-11-17 12:22:00 |
PAR Share Purchase Plan 2016 - Extension |
0 |
https://app.sharelinktechnologies.com/announcement/asx/089f12a533875316772008ba052e3f9b |
|
2016-11-22 09:18:00 |
Paradigm's hay fever clinical trial cleared to commence |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a7d551f70eb1c19af923c7c45914bdbd |
|
2016-11-30 09:28:00 |
Managing Director's Presentation to AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4298cf18bd5301e8e676403c02bf9cf7 |
Chairman's Address to Shareholders
|
2016-11-30 12:40:00 |
Results of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81c311b15c131815054da2bf80ec9e99 |
|
2016-12-02 16:35:00 |
Closure of SPP |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34973a98b5f4b259000a3be42c1d2f98 |
|
2016-12-09 09:17:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a7c0747b93ff06e3eb206a4cdd9cca87 |
|
2016-12-09 09:19:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c5e9d23f793f8ac6891b5dcdcba2c787 |
Change of Director's Interest Notice
|
2016-12-09 09:24:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dfba33561447bc31889b5517c7e7c298 |
Change in substantial holding
|
2016-12-09 17:38:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71c213d082df1c5e3bc3fa4671720408 |
Change of Director's Interest Notice
|
2016-12-09 17:40:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/85727abd07c38627608592ec9a6a5932 |
Change of Director's Interest Notice
|
2016-12-15 11:29:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c870c889b0ca914ac781b0943d2a8e77 |
Change of Director's Interest Notice
|
2016-12-16 12:29:00 |
Broker Initiated Coverage |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01a17ee43db28356f64e05351c2384b9 |
|
2017-01-19 10:01:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7dee694e759253b78409919e6b729fd8 |
|
2017-01-20 10:42:00 |
Shares released from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/32bddba74764261550e3b61dee0c0930 |
|
2017-01-25 09:14:00 |
Recruitment complete in Paradigms hay fever clinical trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/17f885e353c68d924388016099538abb |
|
2017-01-31 14:56:00 |
Quarterly Cashflow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3cf7240a7a87181419cb0145cb0b4fb5 |
Commitments Test Entity - Second Quarter Report
|
2017-02-07 16:07:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ad9b90e96ae120306f288fe0101265f9 |
|
2017-02-24 17:10:00 |
Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ccccc7456a17fc2016e51339ea1cd6f9 |
Half Year Directors' Statement
Half Year Directors' Report
|
2017-03-02 09:37:00 |
Broker Research Report for Paradigm Biopharma |
0 |
https://app.sharelinktechnologies.com/announcement/asx/443bc89c309d6a18c3ebe5d2ef710212 |
|
2017-03-07 13:47:00 |
Paradigm Update Ross River Virus Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7afa652b468610eda877e62d59378724 |
|
2017-03-21 09:15:00 |
Paradigm Presents to Asian Investors |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a70e4d5b06f9f6c8d57ea94b4131cdf |
|
2017-03-22 09:25:00 |
Paradigm receives $1.34 million R&D tax incentive rebate |
1 |
https://app.sharelinktechnologies.com/announcement/asx/21a4f415ed6c60c83f2873a9f3d77e15 |
|
2017-03-23 09:12:00 |
Final participant treated in Phase 2 hay fever trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/66fcc7fd0ccce255b19731cd7b22310c |
|
2017-04-28 09:37:00 |
Paradigm March Quarter Update & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ca73c45fac80e5dfa17a5ec9b413feee |
Commitments Test Entity - Third Quarter Report
|
2017-05-11 09:28:00 |
Paradigm Government grant for Ross River virus research |
1 |
https://app.sharelinktechnologies.com/announcement/asx/31148c93d46290fc5f47ee2582ba00d2 |
|
2017-05-15 16:36:00 |
Paradigm Non-Deal Roadshow Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de11308b1bfd8873b96eb6fd46a301b5 |
|
2017-05-16 08:29:00 |
Paradigms preclinical hay fever trial published |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5b00913e241b344bd3de54378c02cb93 |
|
2017-05-22 08:43:00 |
Paradigm Receives Ethics Approval for Ross River Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/336f2d1480570175057c1b85717a155b |
|
2017-06-15 09:01:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3f3068673a9e10c537d262172bc8bf0e |
|
2017-06-16 09:00:00 |
Hay Fever Trial Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2c4ced73506b509c9480b3cfa583a020 |
|
2017-06-19 15:38:00 |
Q and A on Hay Fever Program |
0 |
https://app.sharelinktechnologies.com/announcement/asx/286c135aacf3b559e5d9a0a68f219d43 |
|
2017-06-20 08:59:00 |
Paradigm Enters Heart Failure Market |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6a05bc20e88cb586633a3f775a55e2ee |
|
2017-06-26 10:13:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f23e8618b995259f91379476052364de |
Change of Director's Interest Notice
|
2017-06-28 09:35:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c11ac8314904900c243330837cc4b04 |
Change in substantial holding
|
2017-07-04 17:53:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/78d451f8112b4689b2aea9e080fb38c9 |
|
2017-07-10 08:28:00 |
Paradigm To Commence Phase 2 Ross River Virus Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7a75d0fbb5d72ebdc3fd9ea05194baa1 |
|
2017-07-28 09:22:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d8e5346d32c207685b9297dd98ac41f8 |
Commitments Test Entity - Fourth Quarter Report
|
2017-08-03 14:00:00 |
Shares released from escrow |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fdb70f56abad2f92c42bf756fd2e2741 |
Alteration to issued capital
|
2017-08-09 09:20:00 |
Paradigm (PAR) - First Ross River Trial Participant Treated |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ca667c273c4baa33c76822215aaeddb9 |
|
2017-08-21 09:28:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8db867f756fb67112f54cc42cc1d4326 |
|
2017-08-29 17:35:00 |
Appendix 4E and 2017 Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1b848e1ef63229b67ee5c7c5ea8e5dc1 |
Full Year Directors' Statement
Full Year Directors' Report
|
2017-08-29 17:38:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d46f8fb53dde4b0e02c52f74193ca66 |
|
2017-09-11 08:37:00 |
A PARADIGM SHIFT IN TREATING OSTEOARTHRITIS PAIN |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8ab9c28b1c115eae8df4ee9e0dc8d383 |
|
2017-09-14 09:29:00 |
Paradigm Phase 2 Ross River Virus Clinical Trial Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/98c6420dd0b2d36d71ab8121e833e15d |
|
2017-09-19 08:34:00 |
PARs Osteoarthritis Phase 2 Receives Ethics Approval |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9ff8014322a5b0ea6310197784108bf4 |
|
2017-09-28 12:17:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4cd919245ddc996cdabcbd268316f8cd |
|
2017-10-10 09:12:00 |
PAR REPORTS PAIN REDUCTION IN 83% OF OSTEOARTHRITIS PATIENTS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bd9ae852cc793cf605ca1a46aafd5a9f |
|
2017-10-10 16:41:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/937ec9229698488ce4dde5b643ffd4f9 |
Notice of Annual General Meeting
|
2017-10-11 10:08:00 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8ac3c551e4636ec9f0210f7889af5f52 |
|
2017-10-30 08:39:00 |
First Participant Dosed in PARs Phase 2b OA Clinical Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cdfabb25ea30bd4362c07a4d888287b5 |
|
2017-10-31 16:18:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e593c090f10bb6b0c8bc82d275da9e35 |
Commitments Test Entity - First Quarter Report
|
2017-11-02 08:28:00 |
PAR Updated Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b3f616f49df18efe319b88047156ee2c |
|
2017-11-02 08:53:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fa445d63c685e127fce6502d6d49cf0b |
|
2017-11-06 09:30:00 |
PAR Successfully Completes A$5.75m Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e93905d27c982ff4de1b1d583fd139a0 |
|
2017-11-10 10:01:00 |
CEO Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/84584a31b82877526763b306c52a7525 |
Chairman's Address to Shareholders
|
2017-11-10 12:40:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1039aadf94e25b329392b012c84daeb7 |
|
2017-11-13 16:56:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/19d07d1a2ab65cdd2a12114503ad66e6 |
|
2017-11-14 08:38:00 |
Paradigms ACL Phase 2 Clinical Trial Success |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0a75487dbaa4923329d533b3596f9ea4 |
|
2017-11-15 09:46:00 |
Cleansing Notice - Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4e825dcf9546e144b5dddd5f637ddde9 |
|
2017-11-15 11:03:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e14b20c026bbec3631946f4ceef2475f |
Change of Director's Interest Notice
|
2017-11-15 11:10:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7fe26377e5ad7aef695a2d0171cc1147 |
Change in substantial holding
|
2017-11-16 17:12:00 |
Appendix 3B and Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af48611f8734d7425131f65370318f6c |
|
2017-11-23 08:27:00 |
Paradigms Two Arthritis Phase 2 Clinical Trials on Schedule |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fff406ffe506bb529537c733e599c645 |
|
2017-12-20 13:55:00 |
Paradigm Shareholder Newsletter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a774fccc7ad0902ececf8f40c82b7e53 |
|
2018-01-16 08:31:00 |
PARs European Patent Granted for Bone Marrow Edema Lesions |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eb665efc1e1e036fab881e184ed57b69 |
|
2018-01-24 09:55:00 |
Elite sportspeople successfully treated with PPS |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abb014c66ed726a33d5ad683c06bdaec |
|
2018-01-30 10:30:00 |
Quarterly Update and Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1203c23c0b0b2d136fbbca1ff86251cd |
Commitments Test Entity - Second Quarter Report
|
2018-02-22 17:30:00 |
Half Year Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/dfb7d828ca091f45055f96462bd4f25d |
Half Year Directors' Statement
Half Year Directors' Report
|
2018-03-01 08:18:00 |
PARADIGM REPORTS OSTEOARTHRITIS PAIN REDUCED BY 50% |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fdfe173866a95069c1f8078ed796626b |
|
2018-03-27 10:05:00 |
PARADIGMs PHASE 2 CLINICAL DATA UPDATE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6b3e0b47a6b48eaed82376e0ebf44df8 |
|
2018-04-13 17:25:00 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec783a595efdeb78a2b5c8709c846c9d |
|
2018-04-17 09:38:00 |
PAR Non-Deal Roadshow Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d06d93ff5ee913170f3d4e64092edbb0 |
|
2018-04-30 08:21:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7505fefb7cbe05cae0861a6578e18abd |
Commitments Test Entity - Third Quarter Report
|
2018-05-07 19:04:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f110e84b1547d0ae2ece388c4ac883a |
|
2018-05-08 09:59:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/192ab3e8df3a6dc8206cfbc3ab860db6 |
|
2018-05-08 14:02:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d83d6a99aa5c12aa0decb510c533845b |
Change of Director's Interest Notice
|
2018-05-17 08:56:00 |
Paradigm OA Phase 2b Clinical Trial over 80% Recruited |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d1ac0b5f9e05fdbd3624e82147f10b56 |
|
2018-05-18 17:06:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5ac0b722e35dae6c8db4658f696328ce |
|
2018-05-18 17:07:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9bdfbbd4272ff1a6efd79fc47a91eab4 |
|
2018-06-15 08:29:00 |
PAR - 50% REDUCTION IN OSTEOARTHRITIS PAIN MAINTAINED |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f4788d641dd040fbec7be3604da9f4df |
|
2018-06-19 16:25:00 |
Appendix 3B and Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d417279075b30b312b9f50412c515a32 |
|
2018-06-26 16:24:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8dcc55823d6f6dde3cd9a7edae95d16 |
|
2018-07-04 17:18:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cc09508ce65e9bf3ccb90c7f0f0daf35 |
|
2018-07-09 09:06:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/54d21aef8182b40f04d53da101380c7a |
|
2018-07-17 17:17:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/77b44010f5e477226c9ba92cf0268567 |
|
2018-07-27 15:52:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/65d3f539bce8a7ed7c1cbf3648df6f32 |
|
2018-07-27 16:03:00 |
Quarterly Report and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/40bac55a6e102d4eb711cca08fbea6e8 |
Commitments Test Entity - Fourth Quarter Report
|
2018-08-06 09:16:00 |
PAR achieves 100 per cent recruitment in Phase 2b OA Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/be968aedb214806392dc24becee3bdf7 |
|
2018-08-08 16:39:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bfb4f3f332a400535e2ec1810fc13b0e |
|
2018-08-15 08:09:00 |
PAR ACHIEVES 60 PER CENT REDUCTION IN OSTEOARTHRITIS PAIN |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d3a426062b867ec7c67a812546d0f30f |
|
2018-08-24 16:20:00 |
Appendix 4E and 2018 Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1af750a8f19307c925f1f4e6a5710227 |
Full Year Directors' Statement
Full Year Directors' Report
|
2018-08-24 16:25:00 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0af65f56c6ffe451a00d5aa9d7d156ae |
|
2018-08-28 12:04:00 |
Phase2a RossRiver Virus Clinical Trial Recruitment Finalised |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fac08e5cec4722048f7676d7af7e4151 |
|
2018-09-25 08:28:00 |
PAR REPORTS PAIN REDUCTION IN OA PATIENTS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/671510eb7ad8e020bf77a74e2d77e0cc |
|
2018-10-23 09:15:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a6381bfbc41a00f2c2df9af41522d925 |
|
2018-10-25 08:57:00 |
Paradigm Raises A$9 Million |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3828815cd35c0955c7bb586c6f74cd2f |
|
2018-10-25 08:59:00 |
Paradigm's Updated Corporate Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/38227ef217f98586aa2a89197eb48c49 |
|
2018-10-25 09:02:00 |
Paradigm Agreement With USA Past Players Network |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2de39465cab8f7763ce5b468ac615179 |
|
2018-10-26 16:49:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a51ed987aeb7e133ea6a895f82b6ce1e |
Notice of Annual General Meeting
|
2018-10-31 09:27:00 |
Quarterly Report and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ae6d1f770c79398378bda4e5df87e93 |
Commitments Test Entity - First Quarter Report
|
2018-11-01 12:14:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/01e67802941a6409dadad12f3995601b |
|
2018-11-07 11:00:00 |
PAR reports pain reduction in 145 people with osteoarthritis |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fd842ee385da7110c94ce0c83f1e4178 |
|
2018-11-15 08:29:00 |
PARADIGM RECEIVES $2.32m R&D TAX INCENTIVE REFUND |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e4624b144baff8c49a5ca49d157cc3bf |
Company Administration - Other
|
2018-11-22 08:29:00 |
Paradigm in-licenses treatment for rare joint disease |
1 |
https://app.sharelinktechnologies.com/announcement/asx/57e63e70215150f504d70dcaa1d7a860 |
|
2018-11-26 12:29:00 |
Paradigm's AGM Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9d0160ae21266fa804ea00f42b490a3a |
Chairman's Address - Other
|
2018-11-26 17:12:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2f533065fb5cbf3ce28b8e2385eb1c0 |
|
2018-11-27 15:34:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b7f9f28687f9affc7dea9d6c53ae1797 |
|
2018-11-30 20:20:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f737e0eb09a2e12111b88a2bd2c3ca98 |
|
2018-12-07 08:30:00 |
PARADIGM REPORTS CONSISTENT OA PAIN REDUCTION |
1 |
https://app.sharelinktechnologies.com/announcement/asx/497824ff9dd7813561c4066dda6dc957 |
|
2018-12-13 13:44:00 |
Appendix 3B and Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2a6ec5a0e1cd4726c6a1c42269d7c9b0 |
|
2018-12-13 13:47:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bca8a02a68468ff81df03a7e711e415c |
Change of Director's Interest Notice
|
2018-12-13 13:49:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c6f4c92303f4f830ad07de1e6dc1f24 |
Change in substantial holding
|
2018-12-14 08:46:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e16cb8a188b543be853053695449291b |
|
2018-12-17 11:30:00 |
PAR - Conference Call Details - Phase 2b OA Results |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1eaa2bb908d2c125acf652d150477de6 |
|
2018-12-18 08:47:00 |
PAR REPORTS SUCCESSFUL PHASE 2 CLINICAL TRIAL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/32c48c1b6e394b137d0897c29353e00c |
|
2018-12-18 08:48:00 |
PRESENTATION OF PHASE 2 CLINICAL TRIAL RESULTS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/371243a094111ccc0c488e78d1d95585 |
|
2018-12-20 08:40:00 |
PARADIGMS SUPPLEMENTARY PHASE 2B DATA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ad72ffa65acd5f68f1f3a595f4b445a4 |
|
2019-01-31 16:52:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9c4223ab027a779ef8abdeac071fcd27 |
Commitments Test Entity - Second Quarter Report
|
2019-02-14 09:41:00 |
PARADIGMS ORPHAN PHASE 2/3 CLINICAL PROGRAM PROGRESSES |
1 |
https://app.sharelinktechnologies.com/announcement/asx/80c5444121fa423a32145cdd73fb8136 |
|
2019-02-14 17:25:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8f3ad8434611ac52781e1bafe697406b |
|
2019-02-21 18:17:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/56cf1d01058f2f20be7efbbd6b5293e4 |
Half Year Directors' Statement
Half Year Directors' Report
|
2019-03-08 08:22:00 |
S&P DJI Announces March 2019 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f8a07fd3d9433d9e785a7a7f7b90aebb |
|
2019-03-08 14:30:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f7f4b7bd4239e429018bd5be177d21ce |
Change of Director's Interest Notice
|
2019-03-13 08:41:00 |
Paradigm (PAR) Updated Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/701504cc7f86d25f0ee216dbd2966947 |
|
2019-03-28 08:59:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5e7bfea8286d68bdda73c14188760f7e |
|
2019-04-11 09:04:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/52752d718ee562f41e2d52812ca29a81 |
|
2019-04-15 09:14:00 |
PARADIGMS SECONDARY ENDPOINTS SUCCESSFULLY MET |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9fe3dc76fd51b4a6345f9b4542e23c82 |
|
2019-04-15 09:15:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/505b8a4e35092db939f2a6c1f9fe3090 |
|
2019-04-15 09:17:00 |
Cleansing statement under Section 708AA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/647ac4eaba8d401078ab420153560c0c |
|
2019-04-15 09:21:00 |
PARADIGM LAUNCHES A$77.9M CAPITAL RAISE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a4f4185198b62f5c4a31e10f969b7159 |
|
2019-04-15 09:29:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/910425825dedc874f7a81953978f78d2 |
|
2019-04-15 09:31:00 |
PARADIGM UPDATED CORPORATE PRESENTATION |
1 |
https://app.sharelinktechnologies.com/announcement/asx/47595154d6700f1f6761afc6a09c214c |
|
2019-04-17 08:58:00 |
Paradigm Confirms Capital Raise Commitments |
1 |
https://app.sharelinktechnologies.com/announcement/asx/79fb975b86a38785e9fe64793a400d85 |
|
2019-04-17 09:00:00 |
PAR Accelerated Non-Renounceable Rights Issue Offer Booklet |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ef0715935a0de8adfb7ecf84db78e20c |
|
2019-04-23 16:43:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71eead6b2e2a461d38561feb44c4e24e |
Change of Director's Interest Notice
|
2019-04-24 08:26:00 |
Cleansing statement under Section 708AA |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8c8bf2ba1fce878aa43d9e78f049467 |
|
2019-04-24 09:39:00 |
Completion of Institutional Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/304d4c96525969ffe6db2b060e45fdb6 |
|
2019-04-26 09:05:00 |
Cleansing Notice under section708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9f66260e6c759092645fc0162da8773d |
|
2019-04-26 09:06:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a30e153324cd47999da507445715f04 |
|
2019-04-30 11:41:00 |
Quarterly Report and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/be571e30ddd45fbda2bbf034c757eedd |
Commitments Test Entity - Third Quarter Report
|
2019-05-08 08:23:00 |
Paradigm Corporate Update - May 2019 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eb3c5ffe35350aebf543fc5f0dca56e3 |
|
2019-05-09 08:23:00 |
Successful Completion of Retail Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9bdea080cbd71ccbfb50684799d6c2d4 |
|
2019-05-13 08:36:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/acbab29aee4f3f2cbf7651d28ac36e25 |
|
2019-05-13 09:45:00 |
Updated Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/898b3b18b637d7516765536a11dcf68c |
|
2019-05-21 11:40:00 |
PAR CORRECTS AFR ARTICLE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/215473ea51ad6bab822ab77380c06b3d |
|
2019-05-28 08:24:00 |
PAR reports consistent pain reduction in knee OA of patients |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ad282994a07122c551c2ff02791a2344 |
|
2019-06-04 08:31:00 |
PAR REPORTS SUCCESSFUL ROSS RIVER PHASE 2 CLINICAL TRIAL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7d8b2863c7cf454551f389cf7428c338 |
|
2019-06-28 13:10:00 |
Paradigm EOFY Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c3f1bb97aff6009ada9fe575dea0dfad |
Company Administration - Other
|
2019-07-02 09:46:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/53baf2a3675e6817b289771c6f98983e |
Change of Director's Interest Notice
|
2019-07-02 09:51:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/43da67940832c127233fab2482c19ac1 |
Change in substantial holding
|
2019-07-03 09:36:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/883bdc617cb9a5d77d620772340a9ff7 |
Change of Director's Interest Notice
|
2019-07-05 09:18:00 |
Response to ASX Appendix 3Y Query |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1fd1d9944358030befe51bf2eea3483 |
|
2019-07-31 11:40:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/700bcd902e4a42f7d4a29ee193cff2b0 |
Commitments Test Entity - Fourth Quarter Report
|
2019-08-07 09:37:00 |
PARADIGM FILES FIRST IND WITH US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4305e105ab4dc05daf6e0d7645ef6bae |
|
2019-08-29 08:27:00 |
PARs drug reduces cartilage degradation in subjects with OA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1801a407c6bff2b2200d2ab1a15c7259 |
|
2019-08-30 12:50:00 |
Appendix 4E and 2019 Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fa42dc2c4a0af69771ac4835a7a1d4af |
Full Year Directors' Statement
Full Year Directors' Report
|
2019-08-30 12:51:00 |
Appendix 4G and 2019 Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e773f669bb6fa7d22578ec6340a312b3 |
|
2019-09-10 10:32:00 |
PAR Expanded Access IND Cleared by US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/959645e49c90f1690f231fa2f06b0cd6 |
|
2019-09-12 16:07:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c2ac272128baf0ab68be4660ac6f2514 |
|
2019-09-17 11:24:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2c0bd5830598e4e0cd6d04b0a65fbe1f |
|
2019-09-24 17:13:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ba4664d7591f462d921dec67fa8be42 |
|
2019-09-30 08:13:00 |
Osteoarthritis pain reduced by Paradigms Zilosul (PPS) |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a9ac8668b4ee12ddae5ee7495623de21 |
|
2019-10-01 16:20:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7f40ae6e2f42706b76ac6b34a20d1fad |
|
2019-10-04 11:16:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/570c3ef0b45fbe198084655a8a2a8ea5 |
Notice of Annual General Meeting
|
2019-10-22 17:03:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9a4b5941354261893f1b3c892b247d69 |
|
2019-10-25 08:21:00 |
PARADIGM PROVIDES REGULATORY FILING UPDATE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e1f69b798a75c1f28c47f259d4f85bb2 |
|
2019-10-31 10:11:00 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6f465d669013063eb6b01708a5a6d580 |
Commitments Test Entity - First Quarter Report
|
2019-11-07 10:47:00 |
Paradigm AGM Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5198748818bd316262c11497978b7887 |
|
2019-11-07 18:05:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9f2ecfa04d39440cf352d84d55136b3 |
|
2019-11-11 11:27:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2f697d13e3cf99a5c8d2e2ccb8054634 |
|
2019-11-14 20:05:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cbc1edc4d1b31802f86319edc2f351bf |
Change of Director's Interest Notice
|
2019-11-14 20:11:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f136905d16b0aab4124bb21b2a66fe9 |
Change in substantial holding
|
2019-11-19 16:21:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d3f6f55a22e6c2c8a04813864d8dbe06 |
Change of Director's Interest Notice
|
2019-11-25 16:04:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/14816425ec5ec374efd9af8bb6bcba7a |
|
2019-12-04 08:41:00 |
Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8f8dbaf508b6ccd2faa1a86ff58ca88 |
|
2019-12-04 08:43:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1da92041dc6954f69de254db4de6ad1b |
|
2019-12-12 08:21:00 |
Paradigm End of Calendar Year Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/de0bced66483bf97db4ea96558c49c6c |
Company Administration - Other
|
2019-12-13 16:51:00 |
Cleansing Notice and Appendix 3B |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c4a5e37ef339963f4b4924235ade13e8 |
|
2019-12-18 17:49:00 |
Cleansing Notice and Appendix 3B |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b014b856fcc3abb64b02c3ab5fd2f947 |
|
2020-01-14 16:22:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/460b24186642acda2ebb7c2a58663f79 |
Appendix 2A (Application for Quotation of Securities
|
2020-01-14 16:24:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/60bc652f27c637f19294a0dbafadb273 |
|
2020-01-15 16:18:00 |
Updated Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d10bd900cafc265e2ba43726acd4757 |
Appendix 2A (Application for Quotation of Securities
|
2020-01-31 14:42:00 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d59f2c14a485d4ba65a5dab277134646 |
Commitments Test Entity - Second Quarter Report
|
2020-02-03 16:40:00 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0c99c97b50facfc8a35bb2a6fb975eec |
Appendix 2A (Application for Quotation of Securities
|
2020-02-10 17:17:00 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/54f8ef0d66b03dec884d5e0f300d6502 |
Appendix 2A (Application for Quotation of Securities
|
2020-02-13 08:28:00 |
Paradigm presents MPS VI poster at WORLD Symposium |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b6f094875724d891ca6ffe07eb33931f |
|
2020-02-14 16:27:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/34ed3a57d8db985bf3afccf5443ae0ca |
Half Year Directors' Statement
Half Year Directors' Report
|
2020-02-18 09:12:00 |
Paradigm - first patient dosed in USA under FDA approved EAP |
1 |
https://app.sharelinktechnologies.com/announcement/asx/836c7a6d9d8e3dd292dcf3d71bdc399e |
|
2020-02-21 08:16:00 |
Paradigm reports Positive Pre-IND meeting with US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0862cc91b1fc9578a856692fb6d4bd01 |
|
2020-02-28 16:35:00 |
Appendix 3B and Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a4e2ff7a71606cd46485ffa01f7e9b82 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-03-16 13:48:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/26fd71d9cf9e54e32a778f5ce2e864bd |
Change of Director's Interest Notice
|
2020-03-16 13:51:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/42a166ff1fe076544a778c948e15d74a |
Change in substantial holding
|
2020-03-24 08:22:00 |
All 10 participants in US FDA EAP have commenced treatment |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e2e2351de2ea5cc60487eae55684f6e3 |
|
2020-03-24 08:38:00 |
Paradigm to present at Virtual Conference, Friday 27th March |
0 |
https://app.sharelinktechnologies.com/announcement/asx/26cae0a0711777b15c791e6ca357ad4f |
|
2020-03-24 16:37:00 |
Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ba3de441113eedd7f1152946e4fdae4a |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-04-02 09:21:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/29f51a99f2dd4200a710cc245501c5a3 |
|
2020-04-06 11:54:00 |
Voluntary Suspension |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1a9fcef08a469b65604e7cfe89620673 |
Suspension from Official Quotation
|
2020-04-06 12:21:00 |
Paradigm Latest Corporate Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2010f46c5c091c0a87863bdbb0d9f52d |
|
2020-04-06 12:48:00 |
Paradigm receives clarity on US regulatory pathway |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1ec4e6b18831d5f5b83118e072684730 |
|
2020-04-06 13:07:00 |
Paradigm Reports Very Encouraging Real World Data |
1 |
https://app.sharelinktechnologies.com/announcement/asx/10518408a8a62e114cd106c4e8dded5f |
|
2020-04-07 15:49:00 |
PARADIGM TO HOST INVESTOR CALL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f4a685861afd6b16ed184dabbddbe87e |
|
2020-04-08 10:52:00 |
Proposed issue of Securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9b3e22bec2e8da781c32f5784a7aeee8 |
|
2020-04-08 12:23:00 |
Reinstatement to Official Quotation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/563f4aa715d1f65b223896f3dbf3f453 |
Reinstatement to Official Quotation
|
2020-04-08 12:23:00 |
Paradigm completes $35m raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b21969e1459093a034356cbeb94a804e |
|
2020-04-16 09:29:00 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d16014a6f08dfa337bbfc85cdfd91b95 |
Appendix 2A (Application for Quotation of Securities
|
2020-04-28 08:41:00 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/513894f00e887e619cb5c54b45f0f2a6 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2020-04-30 10:24:00 |
EAP treatment completed and Orphan Status achieved for MPS-I |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e1c55bb5389ce472906c3ec30b535104 |
|
2020-05-12 11:31:00 |
BLOCK TRADE TO INSTITUTIONAL INVESTORS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6ba408b9f020f57b97a5ec033049bcf0 |
Security holder details - Other
Company Administration - Other
|
2020-05-12 11:36:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da60ab34ba24ffe0d30135cedcd883ec |
Change of Director's Interest Notice
|
2020-05-12 11:41:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ca0e66e8300096bdb9deacba2db026c |
Change of Director's Interest Notice
|
2020-05-12 11:43:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8a63e81a2f95a2e686636019576712e |
Change of Director's Interest Notice
|
2020-05-12 11:50:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/29c2673e81559e20c374e294e284cd13 |
Change in substantial holding
|
2020-06-03 08:19:00 |
Paradigm Further Strengthens Senior Management Team |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a088a8ec758e949096769cc014f72245 |
Company Administration - Other
|
2020-06-12 08:16:00 |
S&P DJI Announces June 2020 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0d1b3ff5ef853e83fb2e82b246397eeb |
Standard and Poor's Announcement
|
2020-06-24 09:53:00 |
Resignation of Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06d9c52b69d932e37ad68d647947c3cb |
Director Appointment/Resignation
|
2020-06-26 16:11:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e5d4897205cfa314cbd443d3dd9b1e21 |
Final Director's Interest Notice
|
2020-06-26 18:02:00 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d36279f3a7aba82dc34db51caf4c6a9 |
Appendix 2A (Application for Quotation of Securities
|
2020-07-03 08:47:00 |
Paradigm adds Dr Donna Skerrett as Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/56e8d096757f98b7475fa56f8bba7627 |
Director Appointment/Resignation
|
2020-07-07 17:57:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6ddddd5876901177009dc9fa99fe2533 |
Initial Director's Interest Notice
|
2020-07-15 09:47:00 |
NEW FINANCIAL YEAR UPDATE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2f174f3ed912ad6aaefeef097e142639 |
Company Administration - Other
|
2020-07-17 16:42:00 |
Cleansing Notice and Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c084ee0f4072bb8ea5370208fe96956f |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-07-29 16:04:00 |
Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ec3e5a84f334013b17ef4281b3446080 |
Commitments Test Entity - Fourth Quarter Report
|
2020-07-30 08:29:00 |
EAP - 65% PAIN REDUCTION IN 10 OA PATIENTS IN USA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/53eb6ac3e5970e6fdf32dccc78411a3d |
|
2020-07-31 16:05:00 |
Quarterly Activities Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d7fce572a6a0e53f81710c7b7d17cc18 |
Commitments Test Entity - Fourth Quarter Activity Report
|
2020-08-11 08:47:00 |
MPS RECEIVES CRITICAL APPROVALS AND FEEDBACK FROM AGENCIES |
1 |
https://app.sharelinktechnologies.com/announcement/asx/41dcb8445f591d29b78273f5738e8ad6 |
|
2020-08-28 08:18:00 |
Appendix 4E and 2020 Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5bcbf223863fbffaa7d4ac099f9c72bc |
Full Year Directors' Statement
Full Year Directors' Report
|
2020-08-28 08:20:00 |
Appendix 4G and 2020 Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18f471bc03fd1e53595d685db48d943b |
|
2020-09-17 08:23:00 |
Paradigm Presentation to Emerging Leaders Conference |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2be797ff38d41fe28447fd9c864e304b |
Company Administration - Other
|
2020-09-18 16:49:00 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3bbe8dd9cfa29addc89fc560166dd16c |
Appendix 2A (Application for Quotation of Securities
|
2020-09-28 08:53:00 |
EMA PROVIDES KEY PATH TOWARD PHASE 3 TRIALS AND REGISTRATION |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d3c5ba342661f6069160544b804770a9 |
|
2020-09-29 08:22:00 |
EXTENSION OF EXCLUSIVE AGREEMENT WITH BENE PHARMACHEM |
1 |
https://app.sharelinktechnologies.com/announcement/asx/13947d17399e02ace544a97c5f90da98 |
|
2020-10-01 09:06:00 |
ZILOSUL REDUCES PAIN IN PATIENTS WITH KNEE OA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8f348a3877118c9884c03e6962d927f3 |
|
2020-10-13 08:15:00 |
PARADIGM ADDS MORE TALENTED SENIOR EXECUTIVES TO ITS TEAM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a5b9ad9f004aee71a606c211119f4cc0 |
Company Administration - Other
|
2020-10-15 08:18:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0efbfd49ee7c1f9d97c4badcf832237 |
Notice of Annual General Meeting
|
2020-10-30 12:50:00 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a5944c2dee6bd096596bb44613aa3fde |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2020-11-04 08:22:00 |
Paradigm to present at NWR Virtual Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1b13e73ef5a8333394d706d592aa3a00 |
|
2020-11-06 16:24:00 |
Ordinary Shares Cancellation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/64f8a427aacd985b0c630306c86e2720 |
Alteration to issued capital
|
2020-11-12 08:19:00 |
FIRST PATIENT DOSED IN MPS-I PHASE 2 CLINICAL TRIAL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/60b6361602cfb241eef86e94c9561cab |
|
2020-11-19 10:16:00 |
Paradigm AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e7f2e05d266a94b6708eab197a023b1d |
|
2020-11-19 15:23:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bd1e1fc19a1e97a21138a7b6260ac9b3 |
|
2020-11-20 08:14:00 |
Resignation of Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5fc539c57e76c234752a19f193653fb1 |
Director Appointment/Resignation
|
2020-11-20 16:40:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d046368577e50897f944ffd01e8d50b |
Final Director's Interest Notice
|
2020-11-25 16:09:00 |
Cleansing Notice and Appendix 3G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d9f3fedf349c2f7f205dab37f73f8096 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2020-12-01 12:36:00 |
Paradigm to Present at Evercore ISI HealthCONx Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ddc2fb62affd29611f53dcc5fa3b4588 |
Company Administration - Other
|
2020-12-08 08:25:00 |
Paradigm to Host Inaugural R&D Day |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2bb9745c1197a6231c57f00b1bbfbc66 |
Company Administration - Other
|
2020-12-09 08:20:00 |
Paradigm welcomes Amos Meltzer as Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2b266a79697af3cef6f90f5eca936fd0 |
Director Appointment/Resignation
|
2020-12-14 08:23:00 |
Paradigm Provides Phase 3 Clinical Trial Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ee5b3883321b803214877612c2d48a6f |
|
2020-12-15 18:23:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/394c9563ce720ec9838f496d09774875 |
Initial Director's Interest Notice
|
2020-12-17 16:14:00 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c76ac87805aaa6ea2446fefd4df93cfe |
Appendix 2A (Application for Quotation of Securities
|
2020-12-18 08:40:00 |
PARADIGM RECEIVES POSTIVE FEEDBACK FROM FDA TYPE C MEETING |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8cbeee5830158aba15d50721a00be49f |
|
2020-12-21 09:17:00 |
R&D Investor Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/617e7bfbfe82a28cb0bb0e5a5beb2baf |
|
2021-01-06 08:23:00 |
Paradigm to present at the J.P. Morgan Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0f69e3a0ea19e215737cc8bc36dc9820 |
Company Administration - Other
|
2021-01-12 17:33:00 |
39th Annual JP Morgan Healthcare Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ebf6597ff0ef28d4c372b2ba8a2093d1 |
|
2021-01-18 17:49:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4d6fe20f33ae025093bd5971e7c28a4b |
Change of Director's Interest Notice
|
2021-01-18 17:50:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/caf655bd79b43edeba3ef0025d46e0f2 |
Change in substantial holding
|
2021-01-18 17:50:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/84e6f072a6cfd453cf3cbd5ceb965128 |
Change of Director's Interest Notice
|
2021-01-21 17:27:00 |
Response to ASX Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3eaaf476c9f1b55728890cdd36a65bf8 |
|
2021-01-29 08:22:00 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/20aadba06da2dc861012db51b6d518ba |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2021-02-01 16:57:00 |
Statement pursuant to Listing Rule 4.7C.3 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20989dd1e8ac524bcc435943fdf6b3bd |
Company Administration - Other
Commitments Test Entity - Second Quarter Report
|
2021-02-03 08:18:00 |
Consistent pain reduction and improvement in function data |
1 |
https://app.sharelinktechnologies.com/announcement/asx/731ff3de360dcbd146f5ad46d1064750 |
|
2021-02-11 08:55:00 |
Paradigm Welcomes Helen Fisher as Non-Executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9a118cde1d297de88fad2bd9ab907080 |
Director Appointment/Resignation
|
2021-02-18 10:49:00 |
Ethics Approval Received for Synovial Fluid Biomarker Study |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3ef55fd642e08ee2e9687d2271877ab3 |
|
2021-02-23 08:54:00 |
Paradigm Receives $3.38m R&D Tax Incentive Refund |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03d20d545384045ca44a6bfe45faf533 |
|
2021-02-24 12:13:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3282e6a827cb3a2f096da4d5d011aef1 |
Half Year Directors' Statement
Half Year Directors' Report
|
2021-02-26 16:31:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/313220b571a85691acb5064efe0fa996 |
Initial Director's Interest Notice
|
2021-03-18 09:05:00 |
PHASE 2 RRV DATA PUBBLISHED IN PEER-REVIEWED JOURNAL |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b04a7a984a72250715c8d9e660cc5c67 |
|
2021-03-26 09:40:00 |
Paradigm delivers IND to US FDA for Pivotal OA Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3fbc6ed5975c9a29494ac8ba6f9c35fd |
|
2021-03-31 08:31:00 |
Paradigm and Bene Execute New Collaboration Agreement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/debc188f969c93ce1bb1363597ad6cf0 |
|
2021-04-14 09:16:00 |
Paradigm doses first participant in Synovial Fluid Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/965df9904494fda29f1a3a18f4a1a5ef |
|
2021-04-15 16:25:00 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7c88443d458f594d0c668f227fd56ebb |
Appendix 2A (Application for Quotation of Securities
|
2021-04-26 09:02:00 |
PARADIGM PROVIDES IND APPLICATION UPDATE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f42075f8fe159b3d391beef91eeedcd2 |
|
2021-04-30 08:32:00 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/266b4daa25d34e22a7e80aabe68cfca7 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2021-05-03 09:02:00 |
Paradigm to Present at Truist Securities Life Sciences Summi |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f1df21b768f6ab12221e495227d35301 |
|
2021-05-13 17:10:00 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/123a8137e520746c20b3eac0f0f819e1 |
Appendix 2A (Application for Quotation of Securities
|
2021-05-19 09:00:00 |
PARADIGM ACHIEVES FIRST REVENUE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/306aa8cd1cbfa753c7df6369d2a77c5b |
|
2021-05-21 16:27:00 |
Cleansing Notice and Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8152abaf6f2a0966301bc6aa449583b7 |
Appendix 2A (Application for Quotation of Securities
|
2021-05-25 08:23:00 |
IND QUESTIONS RECEIVED FROM US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/048e781a9350b4cc4a9168b137b2cd30 |
|
2021-06-18 09:09:00 |
PARADIGM RECEIVES KEY REGULATORY APPROVALS FOR MPS VI STUDY |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7651d0d0157e0460c6806b7ce9169239 |
|
2021-06-30 08:22:00 |
PARADIGM SUBMITS RESPONSES TO US FDA QUESTIONS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0fcea43140566828795c692b3430eb58 |
|
2021-07-09 18:17:00 |
NOTICE OF RELEASE OF ESCROWED SECURITIES |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ecd635b1bdb4d4899efbd8915bf33f1 |
|
2021-07-14 18:00:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2ee8732b742ea380846f02c4e1f8bc67 |
Appendix 3H (Notification of cessation of securities)
|
2021-07-19 09:35:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8da798f4aef43b73caf65d96930baad |
Appendix 2A (Application for Quotation of Securities
|
2021-07-29 08:58:00 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fcc321320b9c96de0d583d80b7b6dff5 |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2021-07-30 08:55:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3ea660d479779f8421654b2457044612 |
|
2021-08-03 08:55:00 |
PARADIGM REPORTS IND APPLICATION UPDATE |
1 |
https://app.sharelinktechnologies.com/announcement/asx/76001b108816bfc23189032846c78623 |
|
2021-08-27 08:33:00 |
2021 Annual Report and Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2147d3b8bf6c95130645365a3468649d |
Full Year Directors' Statement
Full Year Directors' Report
|
2021-08-27 08:34:00 |
Appendix 4G and 2021 Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0affdfd3db166138544b303a4595deb5 |
|
2021-09-13 08:22:00 |
CHIKV study data published in Peer-Reviewed Journal |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fac63932494bb262769523fa998be6aa |
|
2021-09-17 16:30:00 |
Notification regarding unquoted securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1a10f72252abaa78edcfff5a40fcab02 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-09-17 16:33:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd4f46b9535c6d722d2a58d3d21532e3 |
|
2021-09-24 08:31:00 |
AUS ETHICS APPROVAL RECEIVED FOR PHASE 3 TRIAL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5df71460d92f6315229f1ee2f56367d3 |
|
2021-09-27 08:23:00 |
PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8c73019adf5eb154a441e74c0c9b7045 |
|
2021-09-30 10:34:00 |
FIRST MPS-VI PATIENT DOSED UNDER PHASE 2 TRIAL IN BRAZIL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0f0ce8e39be338fba16b05defa851245 |
|
2021-10-13 08:29:00 |
POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4f844c0afe4c8dc6b032c2b17453f58c |
|
2021-10-26 09:21:00 |
Phase 2 Synovial Fluid Biomarker Study Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7e7b2a353c762b85d4125e2267bc00e1 |
|
2021-10-28 08:53:00 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/35fbc86acaad4516c82819fe178d5930 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2021-10-29 08:32:00 |
Date of Annual General Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ead1e74840c310630034519f55d766a5 |
|
2021-11-01 08:38:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7528e2a69ea4928ffa078cccdfe4063c |
|
2021-11-03 08:45:00 |
PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b121478233839d867095606cd32ba4db |
Company Administration - Other
|
2021-11-08 08:59:00 |
Global Market Research indicates price for Zilosu |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ea7a05c1926ef535fa92b60af61f6aed |
Company Administration - Other
|
2021-11-09 09:28:00 |
Paradigm Presentation to Bell Potter Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/39b2e972f8c21cf65f3552ab9e6c1982 |
|
2021-11-11 16:18:00 |
NOTICE OF RELEASE OF ESCROWED SECURITIES |
0 |
https://app.sharelinktechnologies.com/announcement/asx/17009928557c1fb14f88d158e8b9150f |
|
2021-11-18 08:22:00 |
Paradigm welcomes Dr Reiter from bene pharmaChem to the team |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9ea9f5454a36cda92a4953a3978a4598 |
Company Administration - Other
|
2021-11-22 08:46:00 |
Paradigm CEO Paul Rennie to transition to Non-Exec Chairman |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5bd14ffc04dd60547ba80065626fb1da |
Company Administration - Other
|
2021-11-23 08:37:00 |
Preliminary Results from Phase 2 MPS I Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/94ceacb43bbc416de1c4794aadcd3e46 |
|
2021-11-24 16:30:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eeaefd63d94cd6d4eb18a1a57031c142 |
Appendix 2A (Application for Quotation of Securities
|
2021-11-30 09:36:00 |
Paradigm Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8cb0c6ed6dd4cd7fa38f32979d76d739 |
|
2021-12-02 10:03:00 |
Paradigm Presentation for Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1d143b8f0cc4c708f07df385fe4bb5ac |
|
2021-12-16 12:29:00 |
PAR REPORTS POSTIVE TOPLINE RESULTS IN HEART FAILURE MODEL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2f3b2b340dae93c54889c174e009b420 |
|
2021-12-24 08:23:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48677b7db3acaf445a5c5c49336b4ce4 |
Notice of Annual General Meeting
|
2022-01-12 16:34:00 |
Paradigm to present at the J.P Morgan Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/642274c34623a75ee8b4d34f631683cf |
|
2022-01-13 08:29:00 |
PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5f895b4579e0e82508b43915c68c91ba |
|
2022-01-25 09:31:00 |
Paradigm AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce4cb3ced0031c08e0afe7ca937a886e |
Chairman's Address - Other
|
2022-01-25 15:35:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/18ece4214f936f751c33f91360f56886 |
|
2022-01-31 15:15:00 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/82d7d125d11bb6f0ece49172a939258f |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2022-02-01 16:07:00 |
Notification regarding unquoted securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/deedf1140fd49d76f804d2cd9d4b03cb |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-02-01 16:09:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6230cf013a99e4f6e8e2d8cda660631d |
|
2022-02-01 16:11:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b1861b54183695d42e368e5a7d1254d7 |
Change of Director's Interest Notice
|
2022-02-11 10:04:00 |
PPS a new adjunct therapy treatment for patients with MPS VI |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a85dcafcafde83849d95eef6bfd5aeca |
|
2022-02-24 09:47:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a4344a29125ad5a651d5190dcbe81c75 |
Half Year Directors' Statement
Half Year Directors' Report
|
2022-02-24 10:15:00 |
Paradigm 1HY22 Key Activity Highlights |
1 |
https://app.sharelinktechnologies.com/announcement/asx/43601d1189c06a04f684c84079859b03 |
|
2022-02-24 12:03:00 |
Amended Appendix 4D |
0 |
https://app.sharelinktechnologies.com/announcement/asx/dd2a56f9a7431c0d81b81a9b132f1eee |
|
2022-03-04 17:02:00 |
S&P DJI Announces March 2022 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/85ae7f5dd2399625c36980bad25ccb21 |
Standard and Poor's Announcement
|
2022-03-09 10:54:00 |
Clarification of recent analyst report on Patent Protection |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ba2db9f6372dfe1dd05f2bb73c8f05c1 |
|
2022-03-09 16:13:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/237c513e728e7155e3747a12b695ce6c |
Change of Director's Interest Notice
|
2022-03-09 16:14:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0124249bf6b37d3dcb53aa2d3290f3ca |
Change in substantial holding
|
2022-03-17 09:20:00 |
UK ethics and regulatory approval for Phase 3 study |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0bd4bd2d4f23744d3cccfff71d0e5a9 |
|
2022-04-12 11:38:00 |
FDA Grants Paradigm Fast Track Designation For OA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d3ce3910e046ad93af80e361326f9d48 |
|
2022-04-28 09:50:00 |
Paradigm Doses First US Subjects under Phase 3 trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cb215a1da7dfee1a57648086dc110191 |
|
2022-04-29 08:42:00 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/397f48cfae2f02091e2479df3a31dc3d |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2022-05-30 08:23:00 |
Paradigm Appoints Experienced US-Based CEO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ce5749dec6387f65c9d29f8ca9dfba6c |
Director Appointment/Resignation
Company Administration - Other
|
2022-06-07 08:23:00 |
Paradigm Receives $8.2m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/57cf2da80716160a2d5d1a60c93afd44 |
|
2022-06-29 16:15:00 |
NOTICE OF RELEASE OF ESCROWED SECURITIES |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e77ddc7d3eaf19bfd2786712f7dfaa1 |
Alteration to issued capital
|
2022-06-30 08:24:00 |
Paradigm Reports Australian Patent Acceptance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c5ba4385975d9586f3c73f458b7a22d8 |
|
2022-07-01 08:30:00 |
100% Recruitment in Synovial Fluid Biomarker Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ba5d2cd6dc841528f165121ded602743 |
|
2022-07-06 08:23:00 |
Paradigm reports global progress in phase 3 study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c8a9b08ad22c1212368fa56154bd2d7b |
|
2022-07-07 16:54:00 |
Notification regarding unquoted securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/abcc9ffb8ab9b9a918d33cc297af8b0c |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2022-07-12 16:21:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6e27e70852389538fbd0547749b1dc13 |
Appendix 2A (Application for Quotation of Securities
|
2022-07-13 10:06:00 |
Paradigm Partners with NFL Alumni Health for OA Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0a5becf4068ca305139e84974e03dad1 |
|
2022-07-14 16:19:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6df91a338c4c60bc9e4fe0f5ac76690b |
Appendix 3H (Notification of cessation of securities)
|
2022-07-15 12:56:00 |
Investor Webinar |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fe08e1142a3a6b083cc7233b4402ac86 |
|
2022-07-28 09:19:00 |
Quarterly Update and Appendix 4C - quarterly |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3d2a6d702d6d57d2ff68eef3f563e07d |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2022-08-08 09:03:00 |
Paradigm provides MPS Clinical Program update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a79067f1a1af34e7732e1bb1ef8f754d |
|
2022-08-11 09:35:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2a809f54a13e2890707718e48b898a8a |
|
2022-08-15 08:59:00 |
Paradigm Launches $66M Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e51706f0ff3bca4b73e0cb150bf8406a |
|
2022-08-15 09:00:00 |
Investor Presentation - $66m Capital Raise |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0b6f536abad64f0533507b2fec0a920a |
|
2022-08-15 09:01:00 |
Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa732de5d067f0a85cf65faf19094977 |
|
2022-08-15 09:03:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8faaf37a6f4725cea7b8fc3bf86f2d90 |
|
2022-08-15 18:21:00 |
Letter to Optionholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/192e7d1561cad0c5159c4e48093ab9f6 |
|
2022-08-19 09:06:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/99ce79487fc5f5dc18df7e6f877cb33a |
Appendix 2A (Application for Quotation of Securities
|
2022-08-19 09:11:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0d5dae37349a83ff9c46b21b117b7e5a |
|
2022-08-19 16:57:00 |
Ineligible Shareholder Letter |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0e64d8e3f4e466db37c353c54615e861 |
|
2022-08-22 08:03:00 |
PAR Non-Renounceable Rights Issue Offer Booklet |
1 |
https://app.sharelinktechnologies.com/announcement/asx/00c6d806dffa68a8fc8fe7312549c852 |
|
2022-08-22 08:07:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b434e0a94b12b5001c5849e31a0d4380 |
|
2022-08-23 08:00:00 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f7827d7395224f1ebd1baad7a096f72 |
Becoming a substantial holder
|
2022-08-26 08:57:00 |
2022 Annual Report and Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/be37e1d2bab492f3b5687bb6f8a86c53 |
Full Year Directors' Statement
Net Tangible Asset Backing
Full Year Directors' Report
|
2022-08-26 09:55:00 |
Appendix 4G and 2022 Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fa42cc5b68225d0573b8acf1c4851116 |
|
2022-08-30 08:43:00 |
Paradigm Appoints Interim Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c227b55cc4c8d8e55aabf59bc0b92546 |
Company Secretary Appointment/Resignation
Company Administration - Other
|
2022-09-13 08:21:00 |
Successful Completion of Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/90312012505d918a79467e5a6554092c |
|
2022-09-14 10:59:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/21361a5d876cb280377c83c2ad5b7283 |
Appendix 2A (Application for Quotation of Securities
|
2022-09-14 16:30:00 |
NOTICE OF RELEASE OF ESCROWED SECURITIES |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d2bd3b90a41446be366fb272664c2ce |
|
2022-09-14 17:15:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/28fd5ae37e4ccb3601bd2d80f0fb5a7e |
Appendix 2A (Application for Quotation of Securities
|
2022-09-19 15:38:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef76ff2e2042fa46218e00a1253a74f9 |
Change of Director's Interest Notice
|
2022-09-19 15:39:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/45dd22f60be99827a117dee9f9467c9d |
Change in substantial holding
|
2022-09-23 16:56:00 |
Date of AGM & Closing Date for Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/fd9a87ab87fd2acc49c0bf5d4591a0ea |
Notice of Meeting - Other
|
2022-09-26 09:11:00 |
Successful MPSVI Safety Review and PARA OA 008 Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d5779cc07028942d752d6efe2f42eaba |
|
2022-09-30 08:40:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/54852294de5de25c45c2ad6c7ab1c600 |
|
2022-10-04 09:13:00 |
PAR Reports Successful Primary Endpoint in Phase 2 Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fa31694b6b5919adc469e18a683a3c83 |
|
2022-10-26 09:35:00 |
Paradigm Doses First UK Participant in Phase 3 Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f26d3dc4b067a66d4ee0b92a35fad851 |
|
2022-10-28 13:06:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/92481a7bc400e62aa01976a14618b960 |
Notice of Annual General Meeting
|
2022-10-31 07:57:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f0d6aae6f6ba51c5c7f3dda376ae0e4d |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2022-11-09 09:14:00 |
Bell Potter Virtual Healthcare Conference presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/98ca2071bc2e25053217f8293c0b430e |
|
2022-11-11 09:23:00 |
MPS-VI Program Accepted for Presentation at WorldSymposium |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c9b28efc532e9e7bfcf973955e917868 |
Company Administration - Other
|
2022-11-14 16:51:00 |
Notice of release of escrowed securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f1c8a3af85b62f71afa71130bbc41b0 |
Alteration to issued capital
|
2022-11-18 14:06:00 |
Paradigm Receives $7.4m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9ad82f8c8aa4765715accbeb6d7cb4a6 |
|
2022-11-22 09:21:00 |
Paradigm CEO steps down & Appointment of MD |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a3c5c3235e78df9d268e1a8cca448079 |
Director Appointment/Resignation
|
2022-11-23 16:39:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e37cd49cb74efc160f02eec8595e3849 |
Appendix 2A (Application for Quotation of Securities
|
2022-11-25 12:16:00 |
Cancel - Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0eaf2ef38fa2307b7527eecd1976590f |
Appendix 2A (Application for Quotation of Securities
|
2022-11-25 13:40:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e5578399781ba9a5a9d466b93906892c |
Appendix 2A (Application for Quotation of Securities
|
2022-11-29 08:27:00 |
Notice of Annual General Meeting-Withdrawal of Resolutions |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0271148480ae0ecd19091a4efcf22341 |
Alteration to Notice of Meeting
|
2022-11-29 11:36:00 |
Paradigm AGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d17057af9fe4b72bacdb55579ac02856 |
Chairman's Address to Shareholders
|
2022-11-29 16:18:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ede326d5341d6e01a78fbefd7dd8e8ee |
|
2022-12-08 09:16:00 |
OA Study Data Accepted for Presentation at OARSI Congress |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0aa874ee7c03b7c5f41ab1dfa47382ba |
Company Administration - Other
|
2022-12-12 10:07:00 |
PAR Receives Allowance for Key US Patent |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6b16cf6a6da2fdae82c33efdb73f6654 |
Company Administration - Other
|
2022-12-16 08:15:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ef0b795f5defd36aafc4ab6187654065 |
Change in substantial holding
|
2022-12-22 18:19:00 |
Change of Director's Interest Notice - Rennie |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc404c3d8cb4c7823832309bdfce538d |
Change of Director's Interest Notice
|
2022-12-28 12:06:00 |
Phase 3 OA Trial to Proceed after Formal Safety Review |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d25cd88a5a46b231de1126597283f2c7 |
|
2022-12-30 10:12:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03d1dbf48c2e048b022d27b4683b45a5 |
Appendix 3H (Notification of cessation of securities)
|
2023-01-10 16:04:00 |
Appendix 4G & 2022 Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f0e256036ffd81d0d788273e2ca288f1 |
|
2023-01-11 18:52:00 |
Paradigm Presentation to JP Morgan Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/08c2463dd4d93b583ea6d89eb41166be |
|
2023-01-19 18:13:00 |
Notice of release of escrowed securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5783eafaf6fc0dd16efbdaa8bdeeb726 |
|
2023-01-31 11:00:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e209e3280d53cdcb867e9bdebda3f82c |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2023-01-31 17:54:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ed1e5ef5452dd7a33d1378f4a085759c |
Appendix 2A (Application for Quotation of Securities
|
2023-02-02 12:51:00 |
Paradigm Increases Presence at OARSI World Congress 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/12ca5fb5f72221a2380c4460965a1a76 |
|
2023-02-27 09:57:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3b1d0d294849915619b2d9a73ba45dda |
Half Year Directors' Statement
Half Year Directors' Report
|
2023-03-02 17:20:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bef53c402dde9690860429859016f7f3 |
Appendix 3H (Notification of cessation of securities)
|
2023-03-03 08:15:00 |
Change of Chief Financial Officer |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d47afba3b4550d0e266a60e7d2210f9f |
Company Administration - Other
|
2023-03-14 08:15:00 |
PAR Receives European Regulatory and Ethics Approval |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a0774ffc3a1344e2f458c15c5998aac2 |
|
2023-03-21 09:53:00 |
Paradigm to present at the NWR Virtual Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ca68e7412dc9619d4502fc392126eb0 |
|
2023-03-22 09:14:00 |
NWR Virtual Healthcare Conference Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ce563f142e3785a474f0955d7f30395b |
|
2023-03-27 16:08:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7ce8ecc000a6b5b96c8a82ee20139991 |
Appendix 3H (Notification of cessation of securities)
|
2023-03-28 08:18:00 |
PAR Poster Presentation to OARSI World Congress 2023 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/04274f7b38fc8045c1d04720d58dc966 |
Company Administration - Other
|
2023-03-31 09:21:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5082ff967f062001082bd4c10ecdc754 |
|
2023-04-04 09:29:00 |
iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/63a249bdb0b4e5e1dc93c8ee2644f3a2 |
|
2023-04-28 09:53:00 |
PAR Phase 2 MPS VI clinical trial completes enrolment |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c1efe6b51c965d935e5b4ad8dd2b8160 |
|
2023-04-28 14:24:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f82971299ce2f26396131cc3eaeb356b |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2023-05-17 16:26:00 |
Change of Director's Interest Notice - Rennie |
0 |
https://app.sharelinktechnologies.com/announcement/asx/129d296931e7cc9494ba1f5c7b7d97c4 |
Change of Director's Interest Notice
|
2023-05-22 16:34:00 |
Change of Director's Interest Notice - Fisher |
0 |
https://app.sharelinktechnologies.com/announcement/asx/25402a610f355b749afc58496b11fb7b |
Change of Director's Interest Notice
|
2023-06-01 08:21:00 |
iPPS shows 3-year equivalent durability in OA Canine Study |
1 |
https://app.sharelinktechnologies.com/announcement/asx/179203e8333a569490127ab50f672deb |
|
2023-06-06 12:28:00 |
Primary and Secondary endpoints met in MPS I Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/688f748aa01acf61b43751f21543df92 |
|
2023-06-29 16:43:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb721cf1e3c0129a09fe962b7778fb26 |
Appendix 3H (Notification of cessation of securities)
|
2023-07-04 08:19:00 |
PAR Reports Phase 3 Clinical Trial Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b61fd18784db94cb14f15d1b511ba964 |
|
2023-07-10 14:14:00 |
Notice of release of escrowed securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7049302f8f7ac07a6e37e4574c57f139 |
|
2023-07-20 13:03:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ae11db135ad773d0a1c547ad1f0e099b |
Appendix 2A (Application for Quotation of Securities
|
2023-07-27 08:18:00 |
Study demonstrates Bene PPS is unique |
0 |
https://app.sharelinktechnologies.com/announcement/asx/55f39abc6e38096f2671a2ceb4199e9c |
|
2023-07-31 11:58:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/373f8ce6475404d60cc608fd290e715c |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2023-08-25 15:53:00 |
2023 Annual Report and Appendix 4E |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6758dac693e58364e945b47bf05fa67a |
Full Year Directors' Statement
Full Year Directors' Report
|
2023-09-01 09:13:00 |
Paradigm Accepted for Presentations at Major Conferences |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a2d5b1947ac528e0c9e905531a30392d |
Company Administration - Other
|
2023-09-01 12:21:00 |
Notice of release of escrowed securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6b6afb9f68dac1ad2df694cb4d7e977a |
Alteration to issued capital
|
2023-09-01 18:01:00 |
Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/43c50a6dfc6775317de8f379f7637b99 |
|
2023-09-01 18:01:00 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d8fab582160a4a34650c2386a11f8dbb |
|
2023-09-13 11:50:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/af03ab2c74bd9d43d855f052c994656e |
Appendix 2A (Application for Quotation of Securities
|
2023-09-22 12:34:00 |
Change of Share Registry Details |
0 |
https://app.sharelinktechnologies.com/announcement/asx/228d8170096f0a05399790348f2c1de8 |
Details of Share Registry address
|
2023-10-03 18:53:00 |
Date of AGM & Closing Date for Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/de359b3892de2b6db1222c46bccd4a05 |
Notice of Meeting - Other
|
2023-10-06 08:53:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2d80ad6b42e46b85aa3f3871dd91228f |
|
2023-10-10 09:23:00 |
iPPS SIGNIFICANT OA PAIN REDUCTION AT 12 MONTHS |
1 |
https://app.sharelinktechnologies.com/announcement/asx/76393c2170325bd8cd425f9c4d0ffaae |
|
2023-10-16 08:47:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a645eb2ef4989324b17f4c36ccf6f57f |
|
2023-10-18 09:18:00 |
iPPS Increases Cartilage Thickness in Phase 2 Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/058732021c8928f27d89da8502ca692a |
|
2023-10-20 18:21:00 |
Resignation of Non-executive Director |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9725f115f93c78361ded8e8a1c35187d |
Director Appointment/Resignation
|
2023-10-23 17:39:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b03cd41c045ec00711aac8cad19a3230 |
Final Director's Interest Notice
|
2023-10-25 14:52:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3955b0e6c797f15212bbebeb939824e7 |
Notice of Annual General Meeting
|
2023-10-30 08:47:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3e188e1a834b02bc3b5df641a66c9e82 |
|
2023-10-30 09:04:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c2b8c3f1056089ace0c9e59afea8fb5 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2023-10-30 09:08:00 |
Paradigm Launches $30M Capital Raising |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7e51a0887aa3277c411bcb39c8a0ff82 |
Company Administration - Other
|
2023-10-30 09:15:00 |
Investor Presentation - $30m Capital Raise |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2b142930a6fab9c711ba98092892513b |
|
2023-10-30 09:21:00 |
Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b6c7da9b6ced7df001f51e1ba27fb99e |
|
2023-10-30 09:23:00 |
Entitlement Offer and Placement Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6e35567268978fa551aea5c6d7b3369e |
|
2023-10-30 13:27:00 |
Update - Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0df5935ebb2e684158aab67852c90c7a |
|
2023-10-31 12:04:00 |
Replacement Entitlement Offer and Placement Prospectus |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c0596457a03d551aab647495fe55e36b |
|
2023-10-31 12:04:00 |
Update - Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f398270b0f068d4c19dd19fccb714a3e |
|
2023-10-31 12:04:00 |
PAR Successful Placement and Fully Underwritten ANREO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d9926baa7f1f3c82845b169e9e4d3d4d |
|
2023-10-31 12:15:00 |
Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/71ce196da8fe3e4cc7627f5142e38a4d |
|
2023-11-01 08:43:00 |
Paradigm to Recommence Trading |
1 |
https://app.sharelinktechnologies.com/announcement/asx/db8611913d598438cf1e202df2ea1f3e |
|
2023-11-03 08:20:00 |
Addendum to Notice of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1156f8c9bfe5c051375deb63949d4e46 |
Alteration to Notice of Meeting
|
2023-11-06 08:28:00 |
Retail Entitlement Offer Open |
0 |
https://app.sharelinktechnologies.com/announcement/asx/927a258a1564a403a476567f39627b89 |
|
2023-11-08 11:35:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e3db256ee7beacb19c500e2f86d23b67 |
Appendix 2A (Application for Quotation of Securities
|
2023-11-10 16:21:00 |
Notice of release of escrowed securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6bdb2da6a51efc398b385d78d395d06e |
|
2023-11-20 12:39:00 |
PAR Pre-AGM Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e2092cdb4cda0c4f302f31d4bf91fe21 |
Director Appointment/Resignation
Company Administration - Other
|
2023-11-20 17:23:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b0c4ce3513093831e2a8ba95a43c2f3 |
Appendix 2A (Application for Quotation of Securities
|
2023-11-21 08:49:00 |
Security Class Suspension from Quotation PARO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2d30d9d030882425539333764b231d37 |
Suspension from Official Quotation
|
2023-11-23 14:17:00 |
Successful completion of Retail Entitlement Offer |
1 |
https://app.sharelinktechnologies.com/announcement/asx/40cdfe0874f3911bd5e430fd67e78ead |
|
2023-11-27 11:43:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6956c48ebc4bbb1ebe9b4b24ee3703fb |
Appendix 2A (Application for Quotation of Securities
|
2023-11-27 12:57:00 |
Listing of Options - Top 20 Holders and Distribution Reports |
0 |
https://app.sharelinktechnologies.com/announcement/asx/217fee57d6cc567a9152059f7584c9aa |
Security holder details - Other
|
2023-11-28 09:22:00 |
Security Class Reinstatement to Quotation PARO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1dbb10e010445223ae6acc7f14a25993 |
Reinstatement to Official Quotation
|
2023-11-29 08:39:00 |
2023 AGM Chairman Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c0506b059ab18cceea12ff8e00d01703 |
Chairman's Address to Shareholders
|
2023-11-29 08:43:00 |
2023 AGM Company Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/59f09537effd78dd72842d1bc87fbda4 |
|
2023-11-29 14:36:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5517f8393aa5343ddd1cf179f0e5e60e |
|
2023-11-30 11:48:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a432b29459a3f358877e4a7b6cb6cda2 |
Appendix 2A (Application for Quotation of Securities
|
2023-11-30 11:55:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ff6883d2518e5f182ecc8940b7638cd1 |
Appendix 3H (Notification of cessation of securities)
|
2023-11-30 14:50:00 |
Change of Director's Interest Notice - Rennie |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6d9765a1107530890f9a13dc15a275fe |
Change of Director's Interest Notice
|
2023-12-01 11:04:00 |
Change of Director's Interest Notice - Fisher |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b624b22749975a52cc115bba11205966 |
Change of Director's Interest Notice
|
2023-12-06 17:08:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c6cce062aa74940149afcfa60d3276a1 |
Change in substantial holding
|
2024-01-15 18:46:00 |
Notice of release of escrowed securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ffcd4b0e77a4daea394806b3da190761 |
|
2024-01-30 09:12:00 |
PAR Selected for Major OA Conference Presentations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/38658eb0b9c0b72a9e3f1c3f13c9886a |
|
2024-01-30 17:22:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3e3328f3d8fc48b828c0d51d9d7c2f89 |
Appendix 2A (Application for Quotation of Securities
|
2024-01-30 17:24:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6da8e2db273c146a2a0619d2e52a36d1 |
Appendix 3H (Notification of cessation of securities)
|
2024-01-31 08:48:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/9a5f417bbc43d26a89e6387460669e45 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2024-02-07 09:14:00 |
Paradigm Receives $7.36m R&D Tax Incentive Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5ef2f56c700836d836f0db8ccd022002 |
Company Administration - Other
|
2024-02-09 09:04:00 |
Primary Endpoint Achieved in Phase 2 MPS VI Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/65ec9d6f0a30b266a0c1b2aede5cfdbf |
|
2024-02-09 16:45:00 |
PAR Appoints Business Development Consultant |
0 |
https://app.sharelinktechnologies.com/announcement/asx/2f3a79f36097d05bd68887a98789520c |
Company Administration - Other
|
2024-02-12 08:26:00 |
Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3d144a49099075c65b412cbe450feda4 |
|
2024-02-13 13:21:00 |
Notification regarding unquoted securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e35b7de6470006fae56aec9c0a88440b |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-02-28 12:15:00 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/4123c65d10671518b7bf15840024429a |
Half Year Directors' Statement
Half Year Directors' Report
|
2024-02-29 10:17:00 |
PAR Employee Performance Rights Plan Issue |
0 |
https://app.sharelinktechnologies.com/announcement/asx/34f267a345117d20c3b0970bef5ccf0d |
|
2024-02-29 10:22:00 |
Notification regarding unquoted securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/efdbb91d505d72bae2e54d152bb44b57 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-03-04 09:14:00 |
Paradigm Board Changes |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8c11f60af76eedb8b4001c33aece608 |
Director Appointment/Resignation
|
2024-03-04 11:20:00 |
Initial Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8d588fa53ea63f41fccdd4288c27ce92 |
Initial Director's Interest Notice
|
2024-03-06 09:27:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ee45c4c35d9f8bdc24286cf34efac622 |
Final Director's Interest Notice
|
2024-03-08 13:17:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/42df352aa6f59a1da5ddaabae92d0daa |
Change of Director's Interest Notice
|
2024-03-08 13:18:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e6c6c3f33543080333b00ed2f112e402 |
Change of Director's Interest Notice
|
2024-03-20 14:45:00 |
PAR to present at NWR Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b727ee326ef6ee663aa6bd9ae45f13d2 |
|
2024-04-05 19:49:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7d5479dace8f5c8f419b53a853fcd713 |
Appendix 3H (Notification of cessation of securities)
|
2024-04-19 08:36:00 |
Type D Response Submitted and Received by the US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/eb90e84098c9b189955068b95b20757d |
|
2024-04-26 16:46:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7762a9ea4e8fabda9a46ee0d6ac5319e |
Appendix 3H (Notification of cessation of securities)
|
2024-04-30 09:54:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/36f2fea5c240b9f74e2e98749be057b1 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2024-05-20 16:03:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/81c72843d811ce45555e845e1a408d01 |
Appendix 2A (Application for Quotation of Securities
|
2024-05-22 08:24:00 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb39fd5dad63b8a84b46b0e0fcce823e |
Change in substantial holding
|
2024-07-31 09:06:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e8e3e476d9a852400d97fa8f39f56bbb |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2024-08-30 10:53:00 |
Appendix 4E and 2024 Annual Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/903480c6bf7191f5bf76bc498bb1ebe8 |
Full Year Directors' Statement
Full Year Directors' Report
|
2024-08-30 10:54:00 |
Appendix 4G and Corporate Governance Statement |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f5e6203fafacf8d26fd57f226ee14368 |
|
2024-09-03 12:23:00 |
Notice of release of escrowed securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9523004788c472596d23d72c6c242d2e |
|
2024-09-10 14:11:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e1bceb8373852a74eb9aeacbe6185081 |
Appendix 2A (Application for Quotation of Securities
|
2024-09-18 08:40:00 |
PAR RECEIVES POSITIVE RESPONSE FROM US FDA FOR PHASE 3 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/07c0418bacdf811772fa5600a449b908 |
|
2024-09-20 14:45:00 |
Date of AGM & Closing Date for Director Nominations |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7e327647440f790fc7f45205770c803c |
Notice of Meeting - Other
|
2024-09-26 17:16:00 |
Ceasing to be a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0abd9b250ddb2327a276b3437cca1e05 |
Ceasing to be a substantial holder
|
2024-10-16 15:24:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/914b2828f92e831b185cf6f811a5c37a |
Change of Director's Interest Notice
|
2024-10-16 15:26:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/778bfacaae9c15d0e115950952873732 |
Change of Director's Interest Notice
|
2024-10-18 13:46:00 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/63c256748adf7c02a71f2d1fa3365100 |
Notice of Annual General Meeting
|
2024-10-21 09:09:00 |
Paradigm Investor Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c5cc1075db3e3d4a8bf866aa2c13f42d |
Director Appointment/Resignation
|
2024-10-22 20:28:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a5d23bd9f64f64e55333d2a3db74011b |
Appendix 3H (Notification of cessation of securities)
|
2024-10-23 18:49:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/48885b345166179c83eed7a659b82f32 |
Change of Director's Interest Notice
|
2024-10-23 18:50:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/26148c2718120ccef0bd25cb8d2a601a |
Change of Director's Interest Notice
|
2024-10-24 08:41:00 |
Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/21e50dc7bc62aba421146dc3236c0071 |
|
2024-10-31 08:20:00 |
Phase 3 Protocol Submission to US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/cf265ce811e31d574a01812bde913b40 |
|
2024-10-31 08:32:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7fd867d1dfd2b091b12a716132d37a36 |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2024-11-19 10:05:00 |
2024 Chairman Address and AGM Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3b1f09b1d403d6a4aded93595268d9f9 |
Chairman's Address to Shareholders
|
2024-11-19 17:58:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ec8072401869c9e606dfbc4e38a03cc6 |
|
2024-11-20 16:56:00 |
Dr. Skerrett Steps Down from Board Following AGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/393dfe64bc7e5067bfbe41b3b7f82746 |
Director Appointment/Resignation
|
2024-11-20 17:42:00 |
Final Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cd0cb7fe1e8727dd498ec4b95e1fea07 |
Final Director's Interest Notice
|
2024-11-21 14:35:00 |
Notification of cessation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bba98fda160916e288a611e119deee27 |
Appendix 3H (Notification of cessation of securities)
|
2024-11-21 14:45:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cb682fa9970750ea9bfa89b156a7ac65 |
Change of Director's Interest Notice
|
2024-11-25 15:45:00 |
Response to ASX Price Query |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2f8d7016fa1e70ba6b0a6fc36cb4008e |
|
2024-11-28 08:33:00 |
Paradigm to Proceed with Phase 3 Knee OA Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0f31b957e47b97890d4a933ff7b4577d |
|
2024-12-04 17:04:00 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3082136d6eb1f1e3b3f43d84d6efe776 |
Appendix 2A (Application for Quotation of Securities
|
2024-12-05 08:36:00 |
Appendix 3H - Notification of cessation of securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f2a04a40180f97c97bcf5c90cc25fc4 |
Appendix 3H (Notification of cessation of securities)
|
2024-12-05 08:45:00 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/07c0dc88f7f7cf07bf26e00913b39cde |
|
2024-12-05 17:12:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/86f7dc00f3846b138b402ef596f61603 |
Change of Director's Interest Notice
|
2024-12-05 17:25:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/709ece94ad6b3624f2b5885eb4908917 |
Change of Director's Interest Notice
|
2024-12-09 09:21:00 |
Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2a6b133e5f3ad0b938271ca4452eb7f |
|
2024-12-09 09:21:00 |
Successful Completion of $16M Placement for Phase 3 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1b1cd12ad6777e76774be9d9954acd9f |
Company Administration - Other
|
2024-12-09 09:24:00 |
PAR Capital Raising Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c965b52df2f2951d0c5aadaf3c1d0e3 |
|
2024-12-13 08:24:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4001249b83d22600bdf781f6a6bc7eaf |
Appendix 2A (Application for Quotation of Securities
|
2024-12-13 08:29:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/03181d73c7efdeab282e181be7ee2632 |
|
2024-12-20 15:25:00 |
Notification regarding unquoted securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/aa82280f68f89f082c41292d16eee9eb |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2024-12-30 12:05:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a13f6e62ab5b7c21f3e041074bcef259 |
Change of Director's Interest Notice
|
2025-01-16 16:22:00 |
Notice of release of escrowed securities |
0 |
https://app.sharelinktechnologies.com/announcement/asx/22f0bb08ef89fc50409686aede99ddc9 |
|
2025-01-24 08:59:00 |
Paradigm Receives $6.3m R&D Tax Refund |
1 |
https://app.sharelinktechnologies.com/announcement/asx/8008220237b91a581234cecda1ca2993 |
|
2025-01-29 18:37:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9e9657a1bc702a71337c28f75896e6d0 |
Appendix 2A (Application for Quotation of Securities
|
2025-01-30 15:28:00 |
Quarterly Activities/Appendix 4C Cash Flow Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f6b24c09aa73d8854dd572a9e78a2eb6 |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2025-01-31 08:19:00 |
PAR Selects Advanced Clinical as CRO for Phase 3 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/093918cce188f411a74eabdd1b0ac8db |
|
2025-01-31 15:39:00 |
Loyalty and Piggyback Options Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0e09638bae6a375f840467f501df4a30 |
|
2025-01-31 16:29:00 |
Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/21ffe3ba78113b5aa21c22ba7ce955da |
|
2025-02-03 08:28:00 |
Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c7e021bf0ae9cf0bef0d8bc0308fe1fe |
|
2025-02-03 08:28:00 |
Cancel - Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/713a2ba643a2fc42e72b1d7156a26ef0 |
|
2025-02-11 09:02:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/20ef8caef638cfd9b82a167bcbf61c18 |
Appendix 2A (Application for Quotation of Securities
|
2025-02-11 09:10:00 |
Listing of Options - Top 20 Holders and Distribution Reports |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b5d9871832e5afdddda46a0fd8299b7 |
|
2025-02-14 14:41:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e9f6dee0f2d010fab66966384e52937 |
Change of Director's Interest Notice
|
2025-02-14 14:41:00 |
Change of Director's Interest Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/88095e9ec5d286d6a4de4bb932b4c41f |
Change of Director's Interest Notice
|
2025-02-24 08:06:00 |
Paradigm Secures Ethics Approval for Phase 3 Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f475000f0b384a8a2e9ad3c0dd902100 |
|
2025-02-28 08:12:00 |
Appendix 4D and Half Year Report |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5935f27b07c5e7914efe30e5e28332f0 |
Half Year Directors' Statement
Half Year Directors' Report
|
2025-03-07 17:01:00 |
S&P DJI Announces March 2025 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/03c483b1123d40471546b916bd860fab |
Standard and Poor's Announcement
|
2025-03-14 15:05:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8d858c6cae0307ba43187abdd3d6441 |
Appendix 2A (Application for Quotation of Securities
|
2025-03-18 15:02:00 |
Paradigm to present at NWR Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9eaff047d7614c55007d2f95ea388c3b |
Company Administration - Other
|
2025-04-29 13:51:00 |
March 2025 Quarterly Activities Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c6c4d1d65c2aa7004d18d385321a66b1 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2025-04-29 16:57:00 |
Notice of General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f108d240ccb43c58e4ff6653d6648167 |
Notice of General Meeting
|
2025-05-15 08:24:00 |
PAR Receives US Ethics Approval for Phase 3 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6ed5cf4eeb325c158b6440b6d1f548fc |
|
2025-05-29 17:10:00 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c65a45263cd6afd3d00bb3686d9e07d4 |
|
2025-06-03 08:41:00 |
Phase 3 Knee OA Trial Begins, Site Live, Patient Consented |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3b1f005617b5eea78bed7839029cbefc |
|
2025-06-26 08:27:00 |
Paradigm Strengthens OA Pipeline with Strategic Acquisition |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f4076d06d9c597439a058822daed983d |
|
2025-06-30 14:07:00 |
US Sites Activated and Patients Consented |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c37972e06a224434c5c4aa9d8b291f6e |
|
2025-07-01 08:31:00 |
Paradigm Secures US$27M to Advance Phase 3 OA Trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3f40a72082f4fe3389977bd85d0c1055 |
|
2025-07-01 08:39:00 |
Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d99e3ac01d6d8af04a7f2bff4e780bf |
|
2025-07-01 08:54:00 |
Proposed issue of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f9f06b9e2c0f7ad1e72246434f2ec0e1 |
|
2025-07-02 12:52:00 |
Application for quotation of securities - PAR |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0578e798142b6ccdcbb2241bd1dad8c2 |
Appendix 2A (Application for Quotation of Securities
|
2025-07-02 12:59:00 |
Notice under Section 708A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/58a3b639aaa43f6de3c7186e33d8d175 |
|